Volume 28, Number 4—April 2022
Research Letter
Early Circulation of SARS-CoV-2, Congo, 2020
Table
Sample | No. tested/no positive (% positive) | p value |
---|---|---|
Sex | ||
F | 655/22 (3.3) | 0.38 |
M | 241/5 (2.1) | |
Unknown |
41/1 (2.4) |
NA |
Location | 0.0052 for Brazzaville 2020 vs. 2019; 0.8 for Brazzaville 2020 vs. Pointe-Noire 2020 |
|
Brazzaville 2019 | 453/4 (0.8) | |
Brazzaville 2020 | 110/6 (5.4) | |
Pointe-Noire 2020 |
374/18 (4.8) |
|
Date | ||
2019 September–December | 453/4 (0.9) | 0.0002 |
2020 January–February |
484/24 (4.9) |
|
Total | 937/28 (3.0) | NA |
*NA, not applicable; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
1These first authors contributed equally to this article.
Page created: February 07, 2022
Page updated: March 19, 2022
Page reviewed: March 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.